TRPV4 and ovarian carcinoma: Results from the univariate Cox regression analysis suggested that TRPV4 was a risk factor for OS in LGG, ovarian cancer, PAAD, THYM, and UVM patients, while it was a protective factor in CESC, KICH, KIRC, and KIRP (Figure 4A).